The platform will undergo maintenance on Sep 14 at about 7:45 AM EST and will be unavailable for approximately 2 hours.
2020
DOI: 10.1111/pin.13006
|View full text |Cite
|
Sign up to set email alerts
|

Peritoneal adenomatoid (microcystic) mesothelioma

Abstract: There are several reports of pleural adenomatoid (microcystic) mesothelioma, but peritoneal adenomatoid mesothelioma is extremely rare. A 64‐year‐old Japanese woman presented with no symptoms and no asbestos exposure history. An abdominal computed tomography scan revealed multiple hypervascular masses on the liver surface, pelvic cavity and anterior peritoneum. Over 10 pieces of the multiple resected tumors showed numerous microcysts composed of a bland mesothelial cell background with rich capillary vessels. … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

2
10
0

Year Published

2020
2020
2022
2022

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(12 citation statements)
references
References 13 publications
2
10
0
Order By: Relevance
“…It is also important to exert caution when making the diagnosis of adenomatoid tumor arising in the peritoneum as this is an extremely rare location for this neoplasm42; therefore, malignant mesothelioma with an adenomatoid/microcystic pattern needs to be excluded through a combination of clinical findings and ancillary testing including loss of BAP-1 immunohistochemistry and CDKN2A homozygous deletion by FISH. The caveats are that a rare case of mesothelioma with adenomatoid pattern can be localized, as described herein, and that some cases of malignant mesothelioma will not show the loss of BAP-1 by immunohistochemistry or the CDKN2A homozygous deletion by FISH 43,44. In contrast, adenomatoid tumors show an intact expression of BAP-1 and a robust membranous staining for L1 cell adhesion molecule (L1CAM) by immunohistochemistry 43,45…”
Section: Discussionmentioning
confidence: 93%
See 1 more Smart Citation
“…It is also important to exert caution when making the diagnosis of adenomatoid tumor arising in the peritoneum as this is an extremely rare location for this neoplasm42; therefore, malignant mesothelioma with an adenomatoid/microcystic pattern needs to be excluded through a combination of clinical findings and ancillary testing including loss of BAP-1 immunohistochemistry and CDKN2A homozygous deletion by FISH. The caveats are that a rare case of mesothelioma with adenomatoid pattern can be localized, as described herein, and that some cases of malignant mesothelioma will not show the loss of BAP-1 by immunohistochemistry or the CDKN2A homozygous deletion by FISH 43,44. In contrast, adenomatoid tumors show an intact expression of BAP-1 and a robust membranous staining for L1 cell adhesion molecule (L1CAM) by immunohistochemistry 43,45…”
Section: Discussionmentioning
confidence: 93%
“…The caveats are that a rare case of mesothelioma with adenomatoid pattern can be localized, as described herein, and that some cases of malignant mesothelioma will not show the loss of BAP-1 by immunohistochemistry or the CDKN2A homozygous deletion by FISH. 43,44 In contrast, adenomatoid tumors show an intact expression of BAP-1 and a robust membranous staining for L1 cell adhesion molecule (L1CAM) by immunohistochemistry. 43,45 The patients in this study received no standard treatment, reflecting time-dependent variations, comorbidities and institutional differences, as some of our patients had been initially treated in other centers.…”
Section: Discussionmentioning
confidence: 99%
“…We conducted a literature search of the PubMed database to understand the current status of adenomatoid mesothelioma in the abdominal cavity. We came across six cases, including our case, that reported an “adenomatoid mesothelioma” (Table 1 ) [ 9 13 ]. There was one man and five women, and none had a history of asbestos exposure.…”
Section: Discussionmentioning
confidence: 99%
“…Recurrence was not observed in five out of six patients, but Mori et al . reported a recurrent case after curative resection (patient 5) [ 13 ]. We should also conduct a careful follow-up with our patient, although the optimal follow-up strategy has not been well established.…”
Section: Discussionmentioning
confidence: 99%
“…The cases presented here highlight the possibility of encountering metastasis of malignant mesothelioma to skin, and definitive pathological diagnosis is important, especially in a patient with relevant history. To our knowledge, there have only been two cases reported 34,35 of unexpected metastatic mesothelioma, one presenting as a gastric polyp 34 and the other as multiple hypervascular masses on the liver surface, pelvic cavity, and anterior peritoneum 35 ; however, none reported to involve skin. Although an uncommon presentation, mesothelioma should be included in the differential diagnosis of tumors that may metastasize to the skin.…”
Section: Discussionmentioning
confidence: 99%